Induction of foot-and-mouth disease virus-specific cytotoxic t cell killing by vaccination

Clinical and Vaccine Immunology

Volumn 18, Issue 2, 2011, Pages 280-288

  Patch, Jared R ^a   Pedersen, Lasse E ^a,b,c   Toka, Felix N ^a   Moraes, Mauro ^a   Grubman, Marvin J ^a   Nielsen, Morten ^b   Jungersen, Gregers ^b   Buus, Soren ^c   Golde, William T ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEUTRALIZING ANTIBODY; TETRAMER; VACCINE; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL KILLING; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; FOOT AND MOUTH DISEASE VIRUS; HYPOTHESIS; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; STAINING; VACCINATION; VIRUS CAPSID;

ADENOVIRIDAE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DRUG CARRIERS; FOOT-AND-MOUTH DISEASE VIRUS; GENETIC VECTORS; SWINE; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VIRAL VACCINES;

EID: 79551495241     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00417-10     Document Type: Article

References (58)

1. Bautista, E. M., G. S. Ferman, and W. T. Golde. 2003. Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV). Vet. Immunol. Immunopathol. 92:61-73.
2. Belsham, G. J., and J. K. Brangwyn. 1990. A region of the 5′ noncoding region of foot-and-mouth disease virus RNA directs efficient internal initiation of protein synthesis within cells: involvement with the role of L protease in translational control. J. Virol. 64:5389-5395.
3. Belsham, G. J., G. M. McInerney, and N. Ross-Smith. 2000. Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells. J. Virol. 74:272-280.
4. Carrillo, C., et al. 2005. Comparative genomics of foot-and-mouth disease virus. J. Virol. 79:6487-6504.
5. Chavez-Galan, L., M. C. Arenas-Del Angel, E. Zenteno, R. Chavez, and R. Lascurain. 2009. Cell death mechanisms induced by cytotoxic lymphocytes. Cell Mol. Immunol. 6:15-25.
6. Childerstone, A., L. Cedillo-Baron, M. Foster-Cuevas, and R. Parkhouse. 1999. Demonstration of bovine CD8+ T-cell responses to foot-and-mouth disease virus. J. Gen. Virol. 80:663-669.
7. Chinsangaram, J., M. Koster, and M. J. Grubman. 2001. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol. 75:5498-5503.
8. de Bruin, T. G., et al. 2000. Discrimination of different subsets of cytolytic cells in pseudorabies virus-immune and naive pigs. J. Gen. Virol. 81:1529-1537.
9. de Los Santos, T., S. de Avila Botton, R. Weiblen, and M. J. Grubman. 2006. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 80:1906-1914.
10. de Los Santos, T., F. Diaz-San Segundo, and M. J. Grubman. 2007. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J. Virol. 81:12803-12815.
11. Denyer, M. S., T. E. Wileman, C. M. Stirling, B. Zuber, and H. H. Takamatsu. 2006. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells. Vet. Immunol. Immunopathol. 110:279-292.
12. Devaney, M. A., V. N. Vakharia, R. E. Lloyd, E. Ehrenfeld, and M. J. Grubman. 1988. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J. Virol. 62:4407-4409.
13. Diaz-San Segundo, F., et al. 2006. Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. J. Virol. 80:2369-2379.
14. Doel, T. R., L. Williams, and P. V. Barnett. 1994. Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. Vaccine 12:592-600.
15. Falk, M. M., et al. 1990. Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. J. Virol. 64:748-756.
16. Golde, W. T., C. K. Nfon, and F. N. Toka. 2008. Immune evasion during foot-and-mouth disease virus infection of swine. Immunol. Rev. 225:85-95.
17. Golde, W. T., et al. 2005. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response. Vaccine 23:5775-5782.
18. Grubman, M. J., and B. Baxt. 2004. Foot-and-mouth disease. Clin. Microbiol. Rev. 17:465-493.
19. Grubman, M. J., M. P. Moraes, F. Diaz-San Segundo, L. Pena, and T. de los Santos. 2008. Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen. FEMS Immunol. Med. Microbiol. 53:8-17.
20. Grubman, M. J., et al. 2010. Adenovirus serotype 5-vectored foot-and-mouth disease subunit vaccines: the first decade. Future Virol. 5:51-64.
21. Grubman, M. J., M. Zellner, G. Bablanian, P. W. Mason, and M. E. Piccone. 1995. Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus. Virology 213:581-589.
22. Guzman, E., G. Taylor, B. Charleston, M. A. Skinner, and S. A. Ellis. 2008. An MHC-restricted CD8+ T-cell response is induced in cattle by foot-andmouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV. J. Gen. Virol. 89:667-675.
23. Ho, C. S., M. H. Franzo-Romain, Y. J. Lee, J. H. Lee, and D. M. Smith. 2009. Sequence-based characterization of swine leucocyte antigen alleles in commercially available porcine cell lines. Int. J. Immunogenet. 36:231-234.
24. Ho, C. S., et al. 2009. Nomenclature for factors of the SLA system, update 2008. Tissue Antigens 73:307-315.
25. Hoof, I., et al. 2009. NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 61:1-13.
26. Joshi, G., R. Sharma, and N. K. Kakker. 2009. Phenotypic and functional characterization of T-cells and in vitro replication of FMDV serotypes in bovine lymphocytes. Vaccine 27:6656-6661.
27. Kuhn, R., N. Luz, and E. Beck. 1990. Functional analysis of the internal translation initiation site of foot-and-mouth disease virus. J. Virol. 64:4625-4631.
28. Leisner, C., et al. 2008. One-pot, mix-and-read peptide-MHC tetramers. PLoS One 3:e1678.
29. Li, X., et al. 2008. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus. Vaccine 26:2714-2722.
30. Mayr, G. A., J. Chinsangaram, and M. J. Grubman. 1999. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology 263:496-506.
31. Mayr, G. A., V. O'Donnell, J. Chinsangaram, P. W. Mason, and M. J. Grubman. 2001. Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs. Vaccine 19:2152-2162.
32. McCullough, K. C., et al. 1992. Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection. Vet. Microbiol. 30:99-112.
33. Moffat, K., et al. 2005. Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport. J. Virol. 79:4382-4395.
34. Moffat, K., et al. 2007. Inhibition of the secretory pathway by foot-and-mouth disease virus 2BC protein is reproduced by coexpression of 2B with 2C, and the site of inhibition is determined by the subcellular location of 2C. J. Virol. 81:1129-1139.
35. Moraes, M. P., G. A. Mayr, P. W. Mason, and M. J. Grubman. 2002. Early protection against homologous challenge after a single dose of replicationdefective human adenovirus type 5 expressing capsid proteins of foot-andmouth disease virus (FMDV) strain A24. Vaccine 20:1631-1639.
36. Nfon, C. K., G. S. Ferman, F. N. Toka, D. A. Gregg, and W. T. Golde. 2008. Interferon-alpha production by swine dendritic cells is inhibited during acute infection with foot-and-mouth disease virus. Viral Immunol. 21:68-77.
37. Nfon, C. K., F. N. Toka, M. Kenney, J. M. Pacheco, and W. T. Golde. 2010. Loss of plasmacytoid dendritic cell function coincides with lymphopenia and viremia during foot-and-mouth disease virus infection. Viral Immunol. 23:29-41.
38. Nielsen, M., et al. 2007. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS One 2:e796.
39. Pacheco, J. M., M. C. Brum, M. P. Moraes, W. T. Golde, and M. J. Grubman. 2005. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology 337:205-209.
40. Pacheco, J. M., et al. 2010. IgA antibody response of swine to foot-andmouth disease virus infection and vaccination. Clin. Vaccine Immunol. 17:550-558.
41. Pauly, T., et al. 1995. Classical swine fever virus-specific cytotoxic T lymphocytes and identification of a T cell epitope. J. Gen. Virol. 76(pt. 12):3039-3049.
42. Pauly, T., et al. 1996. Differentiation between MHC-restricted and non-MHC-restricted porcine cytolytic T lymphocytes. Immunology 88:238-246.
43. Pena, L., et al. 2008. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine. Vaccine 26:5689-5699.
44. Piriou-Guzylack, L., and H. Salmon. 2008. Membrane markers of the immune cells in swine: an update. Vet. Res. 39:54.
45. Robertson, B. H., D. O. Morgan, and D. M. Moore. 1984. Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12. Virus Res. 1:489-500.
46. Rock, K. L., D. J. Farfan-Arribas, and L. Shen. 2010. Proteases in MHC class I presentation and cross-presentation. J. Immunol. 184:9-15.
47. Rodriguez, A., et al. 1996. A porcine CD8+ T cell clone with heterotypic specificity for foot-and-mouth disease virus. J. Gen. Virol. 77(pt. 9):2089-2096.
48. Rodriguez, L. L., and M. J. Grubman. 2009. Foot and mouth disease virus vaccines. Vaccine 27(suppl. 4):D90-D94.
49. Saalmuller, A., T. Pauly, B. J. Hohlich, and E. Pfaff. 1999. Characterization of porcine T lymphocytes and their immune response against viral antigens. J. Biotechnol. 73:223-233.
50. Sanz-Parra, A., et al. 1999. Recombinant viruses expressing the foot-andmouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology 259:129-134.
51. Sanz-Parra, A., F. Sobrino, and V. Ley. 1998. Infection with foot-and-mouth disease virus results in a rapid reduction of MHC class I surface expression. J. Gen. Virol. 79(pt. 3):433-436.
52. Sanz-Parra, A., et al. 1999. Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins. J. Gen. Virol. 80(pt. 3):671-679.
53. Stanway, G., et al. 2005. Virus taxonomy: classification and nomenclature of viruses: eighth report of the International Committee on the Taxonomy of Viruses. Elsevier Academic Press, San Diego, CA.
54. Tesar, M., and O. Marquardt. 1990. Foot-and-mouth disease virus protease 3C inhibits cellular transcription and mediates cleavage of histone H3. Virology 174:364-374.
55. Toka, F. N., C. Nfon, H. Dawson, and W. T. Golde. 2009. Natural killer cell dysfunction during acute infection with foot-and-mouth disease virus. Clin. Vaccine Immunol. 16:1738-1749.
56. Toka, F. N., C. K. Nfon, H. Dawson, D. M. Estes, and W. T. Golde. 2009. Activation of porcine natural killer cells and lysis of foot-and-mouth disease virus infected cells. J. Interferon Cytokine Res. 29:179-192.
57. Yang, M., A. Clavijo, R. Suarez-Banmann, and R. Avalo. 2007. Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus. Vet. Immunol. Immunopathol. 115:126-134.
58. Yewdell, J. W., and S. M. Haeryfar. 2005. Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design. Annu. Rev. Immunol. 23:651-682.